• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清颗粒蛋白前体水平降低可能与帕金森病风险相关。

Reduced serum progranulin level might be associated with Parkinson's disease risk.

机构信息

Neurology Service and CIBERNED, 'Marqués de Valdecilla' University Hospital, Santander, Spain.

出版信息

Eur J Neurol. 2013 Dec;20(12):1571-3. doi: 10.1111/ene.12090. Epub 2013 Feb 9.

DOI:10.1111/ene.12090
PMID:23398167
Abstract

BACKGROUND AND PURPOSE

Common genetic variants (rs5848 and rs646776) have been reported as regulators of blood progranulin (GRN) levels in healthy individuals.

METHODS

To assess the influence of rs5848 and rs646776 polymorphisms in both serum GRN level and risk for common neurodegenerative diseases, we studied 304 patients with Parkinson's disease (PD), 217 individuals with Alzheimer's disease, 131 subjects with mild cognitive impairment, and 126 controls.

RESULTS

The mean concentration of GRN in the serum of patients with PD (319.6 ng/ml) was significantly lower than that of controls (371.5 ng/ml; P = 0.009), whereas there were no significant differences between other groups. Rs646776 minor allele carriers had lower serum GRN levels in each of the four subgroups. There was no correlation between rs5848 genotypes and serum GRN concentrations. Genotype frequencies of both polymorphisms did not differ between groups.

CONCLUSION

Reduced circulating GRN levels might be associated with PD risk by pathogenic factors different from rs5848 and rs646776 polymorphisms.

摘要

背景与目的

已有研究报道常见遗传变异(rs5848 和 rs646776)可调节健康个体的血液颗粒蛋白前体(GRN)水平。

方法

为了评估 rs5848 和 rs646776 多态性对血清 GRN 水平和常见神经退行性疾病风险的影响,我们研究了 304 例帕金森病(PD)患者、217 例阿尔茨海默病患者、131 例轻度认知障碍患者和 126 例对照者。

结果

PD 患者的血清 GRN 平均浓度(319.6ng/ml)显著低于对照组(371.5ng/ml;P=0.009),而其他组之间无显著差异。rs646776 次要等位基因携带者在四个亚组中均具有较低的血清 GRN 水平。rs5848 基因型与血清 GRN 浓度之间无相关性。两种多态性的基因型频率在各组之间无差异。

结论

与 rs5848 和 rs646776 多态性不同,循环 GRN 水平降低可能与 PD 风险的致病因素有关。

相似文献

1
Reduced serum progranulin level might be associated with Parkinson's disease risk.血清颗粒蛋白前体水平降低可能与帕金森病风险相关。
Eur J Neurol. 2013 Dec;20(12):1571-3. doi: 10.1111/ene.12090. Epub 2013 Feb 9.
2
Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort.血清颗粒蛋白前体水平在额颞叶变性和阿尔茨海默病患者中的变化:在西班牙队列中检测 GRN 突变。
J Alzheimers Dis. 2012;31(3):581-91. doi: 10.3233/JAD-2012-112120.
3
rs5848 polymorphism and serum progranulin level.rs5848 多态性与血清颗粒蛋白水平。
J Neurol Sci. 2011 Jan 15;300(1-2):28-32. doi: 10.1016/j.jns.2010.10.009. Epub 2010 Nov 2.
4
Association analysis of the GRN  rs5848 and MAPT rs242557 polymorphisms in Parkinson's disease and multiple system atrophy: a large-scale population-based study and meta-analysis.帕金森病和多系统萎缩中GRN rs5848和MAPT rs242557基因多态性的关联分析:一项基于大规模人群的研究和荟萃分析
Int J Neurosci. 2016 Oct;126(10):947-54. doi: 10.3109/00207454.2015.1086345. Epub 2015 Sep 17.
5
GRN 3'UTR+78 C>T is not associated with risk for Parkinson's disease.
Eur J Neurol. 2009 Aug;16(8):909-11. doi: 10.1111/j.1468-1331.2009.02621.x. Epub 2009 Mar 31.
6
Association between GRN rs5848 polymorphism and Parkinson's disease in Taiwanese population.GRN rs5848 多态性与台湾人群帕金森病的关联。
PLoS One. 2013;8(1):e54448. doi: 10.1371/journal.pone.0054448. Epub 2013 Jan 16.
7
Progranulin genetic polymorphisms influence progression of disability and relapse recovery in multiple sclerosis.颗粒蛋白前体基因多态性影响多发性硬化症的残疾进展和复发恢复。
Mult Scler. 2016 Jul;22(8):1007-12. doi: 10.1177/1352458515610646. Epub 2015 Oct 7.
8
Progranulin gene variability influences the risk for bipolar I disorder, but not bipolar II disorder.颗粒蛋白前体基因变异性影响I型双相情感障碍的风险,但不影响II型双相情感障碍的风险。
Bipolar Disord. 2014 Nov;16(7):769-72. doi: 10.1111/bdi.12180. Epub 2014 Feb 6.
9
Association of progranulin polymorphism rs5848 with neurodegenerative diseases: a meta-analysis.载脂蛋白 E 基因多态性 rs429358 与阿尔茨海默病的相关性:一项荟萃分析。
J Neurol. 2015;262(4):814-22. doi: 10.1007/s00415-014-7630-2. Epub 2015 Jan 13.
10
Progranulin gene variation affects serum progranulin levels differently in Danish bipolar individuals compared with healthy controls.与健康对照相比,颗粒蛋白前体基因变异对丹麦双相情感障碍患者血清颗粒蛋白前体水平的影响有所不同。
Psychiatr Genet. 2017 Jun;27(3):89-95. doi: 10.1097/YPG.0000000000000168.

引用本文的文献

1
Plasma proteomics identify biomarkers predicting Parkinson's disease up to 7 years before symptom onset.血浆蛋白质组学鉴定出可预测帕金森病的生物标志物,其可在症状出现前 7 年预测疾病。
Nat Commun. 2024 Jun 18;15(1):4759. doi: 10.1038/s41467-024-48961-3.
2
Pharmacotherapies for the Treatment of Progressive Supranuclear Palsy: A Narrative Review.治疗进行性核上性麻痹的药物疗法:一项叙述性综述。
Neurol Ther. 2024 Aug;13(4):975-1013. doi: 10.1007/s40120-024-00614-9. Epub 2024 May 14.
3
Adipokines, Vitamin D, and Selected Inflammatory Biomarkers among Parkinson's Disease Patients with and without Dyskinesia: A Preliminary Examination.
帕金森病伴或不伴运动障碍患者的脂肪因子、维生素D及特定炎症生物标志物:一项初步检查
Metabolites. 2024 Feb 5;14(2):106. doi: 10.3390/metabo14020106.
4
Progranulin and GPNMB: interactions in endo-lysosome function and inflammation in neurodegenerative disease.颗粒蛋白前体和 GPNMB:神经退行性疾病中内溶酶体功能和炎症的相互作用。
J Neuroinflammation. 2023 Nov 30;20(1):286. doi: 10.1186/s12974-023-02965-w.
5
Regulation of extracellular progranulin in medial prefrontal cortex.调控内侧前额叶皮质细胞外颗粒蛋白
Neurobiol Dis. 2023 Nov;188:106326. doi: 10.1016/j.nbd.2023.106326. Epub 2023 Oct 12.
6
Progranulin, a moderator of estrogen/estrogen receptor α binding, regulates bone homeostasis through PERK/p-eIF2 signaling pathway.颗粒蛋白前体,一种雌激素/雌激素受体 α 结合的调节剂,通过 PERK/p-eIF2 信号通路调节骨稳态。
J Mol Med (Berl). 2022 Aug;100(8):1191-1207. doi: 10.1007/s00109-022-02233-z. Epub 2022 Jul 15.
7
Inflammation and immune dysfunction in Parkinson disease.帕金森病中的炎症和免疫功能障碍。
Nat Rev Immunol. 2022 Nov;22(11):657-673. doi: 10.1038/s41577-022-00684-6. Epub 2022 Mar 4.
8
AZP2006, a new promising treatment for Alzheimer's and related diseases.AZP2006,一种用于治疗阿尔茨海默病及相关疾病的有前景的新药。
Sci Rep. 2021 Aug 19;11(1):16806. doi: 10.1038/s41598-021-94708-1.
9
Progranulin deficiency leads to reduced glucocerebrosidase activity.颗粒蛋白前体缺乏导致葡萄糖脑苷脂酶活性降低。
PLoS One. 2019 Jul 10;14(7):e0212382. doi: 10.1371/journal.pone.0212382. eCollection 2019.
10
Microglial Progranulin: Involvement in Alzheimer's Disease and Neurodegenerative Diseases.小胶质细胞颗粒蛋白:在阿尔茨海默病和神经退行性疾病中的作用。
Cells. 2019 Mar 11;8(3):230. doi: 10.3390/cells8030230.